Format

Send to

Choose Destination
Haematologica. 2018 Jun;103(6):e249-e251. doi: 10.3324/haematol.2017.175380. Epub 2017 Nov 23.

Survival adjusting for crossover: phase 3 study of ibrutinib vs. chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma.

Author information

1
Stanford University School of Medicine, CA, USA coutre@stanford.edu.
2
ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
3
Medical University of Lodz, Poland.
4
Wilmot Cancer Institute, University of Rochester Cancer Center, NY, USA.
5
Tom Baker Cancer Centre, University of Calgary, Canada.
6
Rabin Medical Center, Beilinson Campus, Petah Tikvah, Israel.
7
Sackler Faculty of Medicine, University, Tel Aviv, Israel.
8
University of Texas MD Anderson Cancer Center, Houston, TX, USA.
9
Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA, USA.
10
University of California, San Diego, Moores Cancer Center, La Jolla, CA, USA.

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center